Search

everythinglearnresearchcommunity

for

Search:↓

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

Pharmacists play a crucial role in patient care and education.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

Minoxidil can slow hair loss and promote regrowth but won't fully restore hair.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Using 5-alpha reductase inhibitors may lower the risk of opioid addiction in men taking opioids.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Minoxidil is the most recommended treatment for hair loss on YouTube Shorts.

Most trichological shampoo ingredients lack strong evidence for effectiveness against hair loss.

Researchers created LabeledIn, a detailed list of drug uses, showing the importance of human input in making such lists.

Herbal supplements like Berberine, Cinnamon, and Fenugreek may be affordable alternatives for managing PCOS.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.